Nadační fond IOCB Tech


The IOCB Tech Foundation was established in 2022 by IOCB Tech, a subsidiary of the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), to which it provides services related to technology transfer.

Tech transfer

The main tasks of IOCB Tech include identification of commercially interesting projects at IOCB Prague, analysis of their patentability and market potential, IP protection, project management, as well as search for commercial partners, and negotiation of licensing conditions.

IOCB Tech has been involved in negotiating and concluding more than a dozen key license agreements with major pharmaceutical companies such as Gilead Sciences, Merck, Novo Nordisk, and SHINE Medical Technologies.


The company has a long history of returning part of its profits earned from its share of negotiated licensing agreements to science. Until 2022, its donations exceeded CZK 50 million (c. USD 2 million). Given the extent and amount of donated funds, IOCB Tech decided to institutionalize and systematically develop its philanthropic activities through a foundation.